glp 1 life extension Enhanced plasma half-life and efficacy of engineered human albumin-fused -1 despite enzymatic cleavage of its C-terminal end appetite balance How Do GLP-1 Receptor Agonists
Description
10.1523/JNEUROSCI.1104-16.2016 [DOI] [PMC free article] [PubMed] [Google Scholar] Gold, R

Medicines that may interact with Wegovy include: Insulin and some diabetes medicines Taking Wegovy with insulin or medicines that increase insulin levels, such as sulfonylureas, may increase the risk of low blood sugar (hypoglycaemia)

The FDA decision is anticipated in October 2025

Lower glucagon levels also contribute to a lower overall appetite
